Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Annales D'Endocrinologie|January 31, 2016
Targeted treatments of radio-iodine refractory differentiated thyroid cancerC de la Fouchardière
The Netherlands Journal of Medicine|February 11, 2004
Coagulopathy in prostate cancerC de la Fouchardière, A Flechon, J P Droz
Gastroenterologie Clinique Et Biologique|March 21, 2008
[Pseudo-Meigs syndrome: particular management of ovarian metastases in colorectal cancer]F Mithieux, R Coriat, C De La Fouchardière, et al.
Diagnostic and Interventional Imaging|March 5, 2015
Thrombocytopenia due to hypersplenism in oncological disease: partial splenic embolization during palliative treatmentH Beji, C De La Fouchardière, F Desseigne, et al.
Bulletin Du Cancer|May 14, 2009
Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" studyP Sève, J Mackey, M Sawyer, et al.
ESMO Open|November 27, 2021
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trialE Assenat, C de la Fouchardière, F Portales, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective studyE Bonnet, C Mastier, A Lardy-Cléaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2009
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLEC de la Fouchardière, R Largillier, Y Goubely, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)S Watson, C de la Fouchardière, S Kim, et al.
ESMO Open|February 13, 2026
Neoadjuvant immune checkpoint inhibitors for localized dMMR/MSI-H gastric cancer: a meta-analysisW K Schwengber, R A Pereira, L F Leite da Silva, et al.
Pageof 2